Lucid Diagnostics Inc. (LUCD)
| Previous Close | 1.9500 |
| Open | 1.9600 |
| Bid | 0.0000 x 900 |
| Ask | 0.0000 x 1000 |
| Day's Range | 1.8100 - 1.9600 |
| 52 Week Range | 1.5100 - 7.7250 |
| Volume | |
| Avg. Volume | 63,952 |
| Market Cap | 72.74M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
PAVmed Provides Business Update and Third Quarter 2022 Financial Results
NEW YORK, November 15, 2022--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the "Company" or "PAVmed"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and presented financial results for the three and nine months ended September 30, 2022.
- Business Wire
Lucid Diagnostics Provides Business Update and Third Quarter 2022 Financial Results
NEW YORK, November 14, 2022--Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), today provided a business update for the Company and presented financial results for the three and nine months ended September 30, 2022.
- Business Wire
Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
NEW YORK, November 10, 2022--Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid", the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), today announced that Lishan Aklog, M.D., the Lucid’s Chairman and Chief Executive Officer, will present an overview of the Company at the CG MedTech, Diagnostics and Digital Health & Services Forum taking place on November 17, 2022 from 11:00 am to 11:25 am EST
